[HTML][HTML] Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas
S Li, X Xie, F Peng, J Du… - … Journal of Oncology, 2022 - spandidos-publications.com
Gliomas are a primary types of intracranial malignancies and are characterized by a poor
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas
S Li, X Xie, F Peng, J Du… - International Journal of …, 2022 - search.ebscohost.com
Gliomas are a primary types of intracranial malignancies and are characterized by a poor
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
[HTML][HTML] Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas
S Li, X Xie, F Peng, J Du… - … Journal of Oncology, 2022 - spandidos-publications.com
Gliomas are a primary types of intracranial malignancies and are characterized by a poor
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas
S Li, X Xie, C Peng - International Journal of Oncology, 2022 - search.proquest.com
Gliomas are a primary types of intracranial malignancies and are characterized by a poor
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
[HTML][HTML] Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas
S Li, X Xie, F Peng, J Du, C Peng - International Journal of …, 2022 - ncbi.nlm.nih.gov
Gliomas are a primary types of intracranial malignancies and are characterized by a poor
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas
S Li, X Xie, F Peng, J Du… - International journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Gliomas are a primary types of intracranial malignancies and are characterized by a poor
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas
S Li, X Xie, F Peng, J Du, C Peng - International Journal of Oncology, 2022 - europepmc.org
Gliomas are a primary types of intracranial malignancies and are characterized by a poor
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …